Table 2 Distribution of PI-RADS score detected by systematic biopsy and MRI-targeted biopsy.
From: The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer
PI-RADS | N | Total prostate cancer | Clinically significant prostate cancer | Gleason sum 6 prostate cancer | |||
|---|---|---|---|---|---|---|---|
Targeted, N (%) | Systematic, N (%) | Targeted, N (%) | Systematic, N (%) | Targeted, N (%) | Systematic, N (%) | ||
3 | 56 | 20 (35.7) | 20 (35.7) | 16 (28.6) | 15 (26.8) | 4 (7.1) | 5 (8.9) |
4 | 59 | 26 (44.1) | 24 (40.7) | 18 (30.5) | 10 (16.9) | 8 (13.6) | 14 (23.7) |
5 | 49 | 42 (85.7) | 37 (75.5) | 34 (69.4) | 23 (46.9) | 8 (16.3) | 14 (28.6) |
Total | 164 | 88 (53.7) | 81 (49.4) | 68 (41.5) | 48 (29.3) | 20 (12.2) | 33 (20.1) |
